179530 — ADBiotech Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for ADBiotech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	11,840	10,632	10,472	11,136	12,897
Cost of Revenue
Gross Profit	5,013	3,113	3,218	4,007	5,148
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	13,465	15,570	17,856	15,809	17,901
Operating Profit	-1,625	-4,938	-7,384	-4,673	-5,004
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-2,415	2,696	-5,457	-9,013	-3,508
Provision for Income Taxes
Net Income After Taxes	-2,664	2,696	-5,432	-8,987	-3,329
Minority Interest
Net Income Before Extraordinary Items
Net Income	-2,664	2,696	-2,863	-7,952	-3,304
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-2,664	1,195	-2,863	-7,952	-3,304
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-341	119	-127	-830	-194
Dividends per Share